Pages that link to "Q39773990"
Jump to navigation
Jump to search
The following pages link to The chemistry, pharmacology and clinical pharmacology of diflunisal (Q39773990):
Displaying 13 items.
- Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis Inhibitors (Q27653350) (← links)
- Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis (Q28276373) (← links)
- Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis (Q34581917) (← links)
- Post-operative analgesia with diflunisal (Q39577048) (← links)
- Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs (Q40157661) (← links)
- A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells (Q40178635) (← links)
- Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants (Q44767199) (← links)
- CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects. (Q47924309) (← links)
- Review of the Animal and Clinical Pharmacology of Diflunisal (Q50122510) (← links)
- Diflunisal (Q57424497) (← links)
- Diflunisal protects human gastric mucosa against damage by indomethacin (Q70923863) (← links)
- Rapid reversed-phase high-performance liquid chromatographic assay of diflunisal in biological fluids (Q71186316) (← links)
- Analysis of Amorphous Solid Dispersions Using 2D Solid-State NMR and 1H T1 Relaxation Measurements (Q84646465) (← links)